脓毒症中的目标心率控制：一条充满希望的道路还是一把双刃剑？
Targeted Heart Rate Control in Sepsis: A Promising Path or a Double-edged Sword?
作者信息
Gudivada Kiran K
机构信息
Department of Intensive Care, The Canberra Hospital, Canberra, Australian Capital Region, Australia.
出版信息
Indian J Crit Care Med. 2024 Dec;28(12):1093-1095. doi: 10.5005/jp-journals-10071-24868. Epub 2024 Nov 30.
Abstract
Gudivada KK. Targeted Heart Rate Control in Sepsis: A Promising Path or a Double-edged Sword? Indian J Crit Care Med 2024;28(12):1093-1095.
摘要
古迪瓦达·KK。脓毒症中的目标心率控制：一条充满希望的道路还是一把双刃剑？《印度重症监护医学杂志》2024年；28(12):1093 - 1095。
相似文献
1
Targeted Heart Rate Control in Sepsis: A Promising Path or a Double-edged Sword?脓毒症中的目标心率控制：一条充满希望的道路还是一把双刃剑？
Indian J Crit Care Med. 2024 Dec;28(12):1093-1095. doi: 10.5005/jp-journals-10071-24868. Epub 2024 Nov 30.
2
Off-label Medication Use: A Double-edged Sword.非适应证用药：一把双刃剑。
Indian J Crit Care Med. 2021 Aug;25(8):845-846. doi: 10.5005/jp-journals-10071-23951.
3
Assessment of Nutritional Status in the Critically Ill.危重症患者营养状况评估
Indian J Crit Care Med. 2020 Sep;24(Suppl 4):S152-S156. doi: 10.5005/jp-journals-10071-23617.
4
Adrenomedullin in Sepsis: Finally, a Friend or an Enemy?脓毒症中的肾上腺髓质素：最终，是友还是敌？
Indian J Crit Care Med. 2020 Dec;24(12):1151-1153. doi: 10.5005/jp-journals-10071-23669.
5
The Clinical Utility of Targeted Heart Rate Control in Septic Shock: A Systematic Review and Meta-analysis of Randomized Controlled Trials with Trial Sequential Analysis.脓毒性休克中目标心率控制的临床效用：一项采用序贯试验分析的随机对照试验的系统评价和荟萃分析
Indian J Crit Care Med. 2024 Dec;28(12):1170-1179. doi: 10.5005/jp-journals-10071-24849. Epub 2024 Nov 30.
6
In Light of the LANDI-SEP Trial: New Evidence or Double Jeopardy?鉴于LANDI-SEP试验：新证据还是双重风险？
Indian J Crit Care Med. 2025 Jan;29(1):84-85. doi: 10.5005/jp-journals-10071-24881. Epub 2024 Dec 30.
7
Is it Time to Develop an Indian Sepsis-related Mortality Prediction Score?是时候开发一个印度脓毒症相关死亡率预测评分系统了吗？
Indian J Crit Care Med. 2024 Apr;28(4):320-322. doi: 10.5005/jp-journals-10071-24693.
8
Sepsis and the Heart: More to Learn.脓毒症与心脏：仍有更多有待了解。
Indian J Crit Care Med. 2022 Jul;26(7):775-777. doi: 10.5005/jp-journals-10071-24262.
9
Presepsin: A Promising Biomarker for Sepsis.前降钙素：一种有前景的脓毒症生物标志物。
Indian J Crit Care Med. 2021 Feb;25(2):117-118. doi: 10.5005/jp-journals-10071-23741.
10
Interleukin-6 in Sepsis-Promising but Yet to Be Proven.脓毒症中的白细胞介素-6：前景可期但尚待证实
Indian J Crit Care Med. 2024 Jul;28(7):629-631. doi: 10.5005/jp-journals-10071-24758.
引用本文的文献
1
In Light of the LANDI-SEP Trial: New Evidence or Double Jeopardy?鉴于LANDI-SEP试验：新证据还是双重风险？
Indian J Crit Care Med. 2025 Jan;29(1):84-85. doi: 10.5005/jp-journals-10071-24881. Epub 2024 Dec 30.
本文引用的文献
1
Beta-blocker treatment in the critically ill: a systematic review and meta-analysis.危重症患者的β受体阻滞剂治疗：系统评价和荟萃分析。
Ann Med. 2022 Dec;54(1):1994-2010. doi: 10.1080/07853890.2022.2098376.
2
β-Blockers, Tachycardia, and Survival Following Sepsis: An Observational Cohort Study.β 受体阻滞剂、心动过速与脓毒症患者生存：一项观察性队列研究。
Clin Infect Dis. 2021 Aug 16;73(4):e921-e926. doi: 10.1093/cid/ciab034.
3
Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.超短效β受体阻滞剂对初始复苏后持续性心动过速的脓毒症患者死亡率的影响：一项随机对照试验的系统评价和荟萃分析。
Chest. 2021 Jun;159(6):2289-2300. doi: 10.1016/j.chest.2021.01.009. Epub 2021 Jan 9.
4
Relationship between norepinephrine dose, tachycardia and outcome in septic shock: A multicentre evaluation.去甲肾上腺素剂量、心动过速与感染性休克结局的关系：一项多中心评估。
J Crit Care. 2020 Jun;57:185-190. doi: 10.1016/j.jcrc.2020.02.014. Epub 2020 Feb 28.
5
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率，1990-2017 年：全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
6
The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses.荟萃分析的统计学意义通常很脆弱：荟萃分析脆弱指数的定义。
J Clin Epidemiol. 2019 Jul;111:32-40. doi: 10.1016/j.jclinepi.2019.03.012. Epub 2019 Mar 30.
7
Outpatient beta-blockers and survival from sepsis: Results from a national cohort of Medicare beneficiaries.门诊使用β受体阻滞剂与脓毒症患者生存率：来自医疗保险受益人的全国队列研究结果
Am J Surg. 2017 Oct;214(4):577-582. doi: 10.1016/j.amjsurg.2017.06.007. Epub 2017 Jun 24.
8
Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis.脓毒症诱导的心脏功能障碍与脓毒症的β-肾上腺素能阻滞剂治疗
J Intensive Care. 2017 Mar 3;5:22. doi: 10.1186/s40560-017-0215-2. eCollection 2017.
9
Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill Patients.心房颤动是危重症患者死亡的独立预测因素。
Crit Care Med. 2015 Oct;43(10):2104-11. doi: 10.1097/CCM.0000000000001166.
10
Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.儿茶酚胺血管加压素治疗期间的心脏不良事件：一项前瞻性观察研究。
Intensive Care Med. 2012 Jun;38(6):950-8. doi: 10.1007/s00134-012-2531-2. Epub 2012 Apr 12.
Zotero 插件